Pacific Biosciences Of California | PACB - Beneficio Operativo

Precio De Mercado
1.40
Cambio Diario
0.01 0.36%
Mensual
-15.96%
Anual
4.89%
Q1 Expectativa
1.29




Beneficio Operativo Cambio Fecha
Agilent USD 353M 90M 2025-12
Bruker USD 76.3M 7.6M 2025-12
Danaher USD 1.5B 348M 2025-12
General Electric Aerospace USD 1.77B 536M 2025-12
Illumina USD 256M 6M 2025-12
Myriad Genetics USD -3M 20.3M 2025-12
Pacific Biosciences Of California USD -53.19M 35.08M 2025-12
Quidel USD -37.3M 667.5M 2025-12
Revvity USD 145.83M 47.49M 2025-12
Roche Holding CHF 9.56B 3.8B 2025-12
Standard Biotools USD -21.92M 1.55M 2025-12
Thermo Fisher Scientific USD 2.3B 226M 2025-12
Waters USD 270.52M 78.4M 2025-12